Disc Medicine (IRON) Cash from Financing Activities (2020 - 2026)

Disc Medicine (IRON) has 7 years of Cash from Financing Activities data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 99.31% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $230.9 million, a 48.32% decrease from a year earlier, with the FY2025 full-year figure at $473.4 million, up 116.85% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $1.7 million, down from $216.7 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for IRON reached as high as $244.3 million in Q1 2025 and fell as low as $22000.0 in Q3 2022.
• Historically, Cash from Financing Activities has averaged $63.6 million across 5 years, with a median of $11.6 million in 2025.
• Across the five-year window, Cash from Financing Activities plunged 99.97% in 2022 and surged 178801.16% in 2023, its largest moves.
• Year by year, Cash from Financing Activities stood at $148.8 million in 2022, then tumbled by 94.79% to $7.8 million in 2023, then jumped by 271.19% to $28.8 million in 2024, then soared by 652.43% to $216.7 million in 2025, then tumbled by 99.22% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $1.7 million in Q1 2026, $216.7 million in Q4 2025, and $11.6 million in Q3 2025.